The global demand for Metabolomics Market is presumed to reach the market size of nearly USD 11.82 BN by 2030 from USD 3.89 BN in 2022 with a CAGR of 14.9% under the study period 2023 - 2030.
Metabolomics is a field of scientific study that focuses on the comprehensive analysis and measurement of small molecules, known as metabolites, within a biological system. It aims to identify and quantify metabolites present in biological samples, such as blood, urine, tissues, or cells, and to understand their roles in different biological processes. The analysis of metabolites provides valuable insights into the metabolic state, biochemical changes, and overall physiological condition of an organism.
The advancements in analytical techniques, such as mass spectrometry and nuclear magnetic resonance spectroscopy, have expanded the capabilities and sensitivity of metabolomics analysis, driving its demand in research and applications. The shift towards personalized medicine has created a demand for comprehensive profiling of patients' metabolomes. The study plays a crucial role in identifying unique metabolic signatures associated with diseases, enabling early diagnosis, stratification of patients, and personalized treatment approaches. The need for accurate biomarkers for disease detection, prognosis, and therapeutic monitoring also fuels the adoption of metabolomics. It is used for drug discovery and development in the pharmaceutical and biotechnology industries. It aids in understanding drug metabolism, identifying drug targets, and assessing drug safety profiles, contributing to optimized drug development processes and patient outcomes. Metabolomics finds applications in agriculture and food science, contributing to crop improvement, food quality assessment, and understanding plant and microbial metabolism. Government initiatives, supportive funding, and collaborations within the scientific community further drive the growth and adoption of this market.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of metabolomics. The growth and trends of metabolomics industry provide a holistic approach to this study.
This section of the metabolomics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product & Service
By Bioinformatics Tools And Services
By Appication
By Indication
By End User
This section covers the regional outlook, which accentuates current and future demand for the Metabolomics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the metabolomics market include Waters Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan), Thermo Fisher Scientific (US), Danaher Corporation (US), Bruker Corporation (US), PerkinElmer (US), Merck KGaA (Germany), GE Healthcare (US), Hitachi High- Technologies Corporation (Japan). Human Metabolome Technologies, Inc. (Japan), LECO Corporation (US). Metabolon, Inc. (US), Bio-Rad Laboratories (US), Scion Instruments (US), DANI Instruments S.p.A. (Italy), GL Sciences (Japan), SRI Instruments (US), Kore Technology Ltd. (UK), and JASCO, Inc. (US) (Total 20 companies). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . METABOLOMICS – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Product & Service
3.7.2 Market Attractiveness Analysis By Bioinformatics Tools And Services
3.7.3 Market Attractiveness Analysis By Appication
3.7.4 Market Attractiveness Analysis By Indication
3.7.5 Market Attractiveness Analysis By End User
3.7.6 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL METABOLOMICS MARKET ANALYSIS BY PRODUCT & SERVICE
5.1 Overview by Product & Service
5.2 Historical and Forecast Data
5.3 Analysis by Product & Service
5.4 Metabolomics Instruments Historic and Forecast Sales by Regions
5.5 Separation Tools (Gas Chromatography, High-Performance Liquid Chromatography, Ultra-Performance Liquid Chromatography, Capillary Electrophoresis) Historic and Forecast Sales by Regions
5.6 Detection Tools (Nuclear Magnetic Resonance (NMR) Spectroscopy, Mass Spectrometry (MS), Surface-Based Mass Analysis) Historic and Forecast Sales by Regio ...